Evidence map›Paper›PMID 28120103›Full record

ArticleHuman genetics2017

Mutations in chromatin regulators functionally link Cornelia de Lange syndrome and clinically overlapping phenotypes.

Ilaria Parenti, María E Teresa-Rodrigo, Jelena Pozojevic, Sara Ruiz Gil, Ingrid Bader, Diana Braunholz, Nuria C Bramswig, Cristina Gervasini, Lidia Larizza, Lutz Pfeiffer and 14 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. SMARCD1 and Its Functional Relevance in SWI/SNF and Cancer.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Expanding the Molecular Spectrum ofInternational journal of molecular sciences · 2022
    Article
  18. Article
  19. Genes · 2022
    Review
  20. Reprogramming of the epigenome in neurodevelopmental disorders.Critical reviews in biochemistry and molecular biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ilaria ParentiSektion für Funktionelle Genetik am Institut für Humangenetik Lübeck, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
María E Teresa-RodrigoUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, University of Zaragoza, CIBERER-GCV and ISS-Aragon, Zaragoza, Spain.
Jelena PozojevicSektion für Funktionelle Genetik am Institut für Humangenetik Lübeck, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Sara Ruiz GilSektion für Funktionelle Genetik am Institut für Humangenetik Lübeck, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Ingrid BaderClinical Genetics Unit, Children's Hospital, Paracelsus Medical University, Salzburg, Austria.
Diana BraunholzSektion für Funktionelle Genetik am Institut für Humangenetik Lübeck, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Nuria C BramswigInstitut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany.
Cristina GervasiniMedical Genetics, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Lidia LarizzaLaboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Lutz PfeifferArztpraxis Medizinische Genetik im Medizin Zentrum Lichtenberg-MZL, Berlin, Germany.
Ferda OzkinayDepartment of Medical Genetics, Faculty of Medicine, Ege University, Izmir, Turkey.
Feliciano RamosUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, University of Zaragoza, CIBERER-GCV and ISS-Aragon, Zaragoza, Spain.
Benedikt ReizInstitut für Integrative und Experimentelle Genomik, Universität zu Lübeck, Lübeck, Germany.
Olaf RittingerClinical Genetics Unit, Children's Hospital, Paracelsus Medical University, Salzburg, Austria.
Tim M StromInstitute of Human Genetics, Technische Universität München, München, Germany.
Erwan WatrinFaculté de Médecine, Institut de Génétique et Développement de Rennes, Rennes, France.
Kerstin WendtDepartment of Cell Biology, Erasmus MC, Rotterdam, The Netherlands.
Dagmar WieczorekInstitut für Humangenetik, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Bernd WollnikInstitut für Humangenetik, Universität Göttingen, Göttingen, Germany.
Carolina Baquero-MontoyaDepartment of Pediatrics, Hospital Pablo Tobon Uribe, Medellín, Colombia.
Juan PiéUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, University of Zaragoza, CIBERER-GCV and ISS-Aragon, Zaragoza, Spain.
Matthew A DeardorffDivision of Human Genetics and Molecular Biology, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Gabriele Gillessen-KaesbachInstitut für Humangenetik Lübeck, Universität zu Lübeck, Lübeck, Germany.
Frank J KaiserSektion für Funktionelle Genetik am Institut für Humangenetik Lübeck, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. Frank.Kaiser@uksh.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coordinated tissue-specific regulation of gene expression is essential for the proper development of all organisms. Mutations in multiple transcriptional regulators cause a group of neurodevelopmental disorders termed "transcriptomopathies" that share core phenotypical features including growth retardation, developmental delay, intellectual disability and facial dysmorphism. Cornelia de Lange syndrome (CdLS) belongs to this class of disorders and is caused by mutations in different subunits or regulators of the cohesin complex. Herein, we report on the clinical and molecular characterization of seven patients with features overlapping with CdLS who were found to carry mutations in chromatin regulators previously associated to other neurodevelopmental disorders that are frequently considered in the differential diagnosis of CdLS. The identified mutations affect the methyltransferase-encoding genes KMT2A and SETD5 and different subunits of the SWI/SNF chromatin-remodeling complex. Complementary to this, a patient with Coffin-Siris syndrome was found to carry a missense substitution in NIPBL. Our findings indicate that mutations in a variety of chromatin-associated factors result in overlapping clinical phenotypes, underscoring the genetic heterogeneity that should be considered when assessing the clinical and molecular diagnosis of neurodevelopmental syndromes. It is clear that emerging molecular mechanisms of chromatin dysregulation are central to understanding the pathogenesis of these clinically overlapping genetic disorders.

Indexed as

MutationPhenotypeAdolescentAdultChildChild, PreschoolChromatinDe Lange SyndromeFaciesFemaleHumansMaleYoung AdultChromatin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.